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Comparison of tetracycline hydrochloride concentrations in 
venous and capillary blood of domestic rabbits (56 pp.)
Director: Todd G. Cochran, Ph.
The purpose of this study was to investigate the feasibility of 
using capillary blood sampling as a method for therapeutic 
drug monitoring and pharmacokinetic analysis. Tetracycline 
hydrochloride was used as a model drug because a convenient 
and sensitive fluorometric analysis was available.
Tetracycline hydrochloride concentrations in serum were 
compared to drug concentrations in whole blood of domestic 
rabbits. Results of this study indicated that there existed no 
significant difference between the two concentrations. The 
original analytical procedure was modified to use a small 
sample volume of 15.7 pL .
The drug concentrations in venous blood and capillary blood 
of domestic rabbits were compared. Results of this study 
demonstrated that tetracycline hydrochloride concentrations in 
capillary blood samples are accurate and unbiased estimators 
of concentrations in venous blood samples.
This study serves as a model for drug analysis using small 
volumes of capillary blood. The finding that there is no 
significant difference in tetracycline hydrochloride 
concentration between venous and capillary blood shows that 
drug monitoring of tetracycline can be performed accurately by 
measuring capillary blood tetracycline concentrations. The 
collection of excess sample or the need to inflict a painful 
procedure on that population where venous blood collection is 
difficult is unnecessary.
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CHAPTER I
INTRODUCTION
The analysis of drug content in plasma or serum typically 
requires venesection and several milliliters of venous blood.
However, blood sampling may pose a problem in pediatric and 
geriatric patients. The patient’s age, weight, disease state, and 
acceptance of procedure, as well as variations in availability of the 
veins for puncture, are all factors in obtaining an adequate blood 
sample. The decrease in subcutaneous and supportive connective 
tissues associated with aging process makes the veins more difficult 
to penetrate (21). As a result of such age related changes, the 
incidence of trauma related to venipuncture is higher among 
geriatric patients. In any form of repetitive study, the determination 
of drug concentration in saliva might alleviate most of these 
difficulties, but unfortunately the effects, side effects and serum 
drug concentrations have not been shown to be correlated with 
salivary concentrations in many cases.
An ideal method for drug determination should be rapid, 
incorporate a simple sampling technique, and require a small sample 
size. The ability of a method to utilize a capillary sampling technique 
without significantly affecting its precision is a great advantage.
With the advent of micro-volume assay methods, capillary blood 
sampling using a finger lancet puncture technique furnishing a whole 
blood sample volume of 100-800 pL  (28), has been used as an 
alternative to traditional venous methods of obtaining blood samples
1
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for clinical determination of blood levels for a number of drugs and 
physiological substances. The advantages of using capillary samples 
are particularly evident in geriatric and pediatric patients. Capillary 
blood sampling provides a less invasive, less traumatic, and often 
less painful method of obtaining blood samples for serum level 
determinations in these patients. This method is being increasingly 
accepted, being a simple procedure easily undertaken by nonskilled 
personnel and by patients themselves. Capillary sampling has 
considerable promise in large-scale screening studies, in pediatric 
studies, in neonatal studies, or in any form of repetitive study 
because capillary blood sampling has substantial practical and 
economic advantages over venous blood drawing.
Previous studies have evaluated capillary and venous blood drug 
concentrations. Plasma cholesterol was measured in 181 subjects 
(12) using two methods: the automated ferric chloride method on 
venous blood and a micro-GLC (gas-liquid chromatography) method 
on capillary blood (20 pL). Mean ± s.d. cholesterol levels were 
essentially identical for the two methods with a correlation 
coefficient of 0.96. A small collector bottle, with a precision-molded 
top, allowed capillary blood from a finger-prick to be automatically 
metered into a diluent for subsequent laboratory analysis (10). This 
device has been sucessfully used by patients to obtain full blood 
counts, glycosylated haemoglobin values and blood glucose 
measurements. For the blood glucose determination a very small 
sample size (capillary blood) of 15 pL showed a good correlation 
(R=0.99) when compared with venous samples of a larger volume. 
Immunoassays of gentamicin using 500-800 pL  blood samples from
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
gentamicin treated children demonstrated no significant difference 
between clinically relevant concentrations of gentamicin in venous 
and capillary blood serum samples (8). Tobramycin serum 
concentrations in capillary samples (100-200 pL) were found to be 
highly correlated (R=0.996, n=73) with those determined in venous 
samples (19). A good correlation was found between capillary and 
venous sample concentrations of theophylline (27) and phenytoin 
(28) with sample sizes of 500-800 pL using the standard finger 
lancet method.
Tetracycline was used as the model drug in the present study 
because a convenient and sensitive fluorometric analysis is available. 
Tetracycline is a broad spectrum antibiotic, effective against gram 
positive and gram negative bacteria, fungi, etc. Though tetracycline 
may be bactericidal to some microbes at high concentration, its 
activity is primarily bacteriostatic. Therefore, it is important that the 
circulating levels of tetracycline be maintained above the minimum 
inhibitory concentration for pathogenic organisms during a course of 
a treatment.
Tetracycline (I) is amphoteric, forming salts with acids or bases. 
The drug is commonly marketed as the hydrochloride salt, in which 
the tetracycline molecule is protonated at the C-4 dimethyl amino 
group.
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The pH of the medium has a great effect on the stability of 
tetracycline and its interaction with other molecules. Most 
tetracyclines are unstable in basic solutions (7). Tetracycline 
undergoes oxidation with atmospheric oxygen (11), which may be 
catalyzed by riboflavin under light (17). Epimerization occurs at the 
C-4 position and leads to the formation of anhydrotetracycline, a 
biologically inactive compound often found in aged tetracycline 
products (24). Dehydration and aromitization of the C-ring lead to 
the formation of anhydro derivatives, a process occuring 
predominantly at low pH.
Tetracycline in biological fluids has been assayed primarily by 
microbiological (7) and fluorometric (13, 14, 18, 29) techniques. The 
disadvantages inherent in microbiological methods are that long 
sample incubation times are required (4), the results may be subject 
to large errors (1), and the assay is limited in specificity since several 
tetracycline like compounds have similar biological activity (20). 
Spectrophotometric methods (2) are insensitive, and interference 
from other material cannot always be excluded. High-pressure liquid 
chromatography (16) and polarographic analysis (5) of tetracyclines
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
also have been described. Fluorometric analysis is relatively simple 
and specific for the tetracyclines (14, 23).
The fluorometric analysis is based on the fluorescence 
quantification of tetracycline extracted from biological fluids. 
Tetracycline forms complexes with many divalent and trivalent 
cations and some of these compounds are strongly fluorescent when 
compared to nonchelated tetracycline. A method combining both the 
extraction and fluorescence was reported by Kohn (14) in which 
tetracycline was extracted with ethyl acetate from solutions 
containing 0.16 M calcium chloride, 1.8 N trichloroacetic acid and 
0.9 M barbital sodium at pH 9. The function of barbital sodium in 
Kohn’s method was to enhance both extraction and fluorescence by 
forming a neutral ternary complex with calcium and tetracycline. A 
structure of this complex (II) was proposed by Kohn based on his 
solvent distribution data.
II
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Comparison between microbiologie and fluorometric methods for the 
determination of tetracycline in dog plasma showed a reasonable 
agreem ent (14).
Pharmacokinetic studies of tetracycline in the domestic rabbit 
following intravenous or oral administration have been reported 
(22). Three male and three female rabbits were injected 
intravenously with tetracycline hydrochloride at lOmg/kg body 
weight. Mean serum pharmacokinetic parameters were elimination 
half-life = 120 minutes and time zero intercept of the log-linear 
elimination phase = 7.5 mcg/mL. The serum concentration vs time 
curve obtained in these studies indicated that a biexponential decay 
model best described the elimination of tetracycline after 
intravenous administration. The tetracycline assay was carried out
using the plate disk method (microbiological method) in these
studies. The correlation coefficient comparing the microbiological 
analysis with fluorometric analysis of serum samples for tetracycline
from five dogs was found to be 0.988 (13).
Several investigators have demonstrated that no clinically 
significant differences exist in the values for hemocrit (6), 
erythrocyte count, hemoglobin, leukocyte count, platelet count (26), 
lipoproteins (9), plasma cholesterol (12), phenytoin (28), gentamicin 
(8), tobramycin (19), and theophylline (3, 27) when venous and 
capillary blood samples are compared. Despite differences in 
methodology and locale of blood sampling, in all instances a good 
correlation has been established between capillary and venous 
sample concentrations.
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The objective of this study was to determine if there exists any 
significant difference between conventional venous samples and 
capillary samples for determination of tetracycline hydrochloride 
concentrations. Use of whole blood samples rather than serum for 
analysis would allow smaller sample sizes to be used, facilitating the 
procedure and causing less trauma to the animal.
It was not feasible to draw enough blood from capillaries of the 
rabbit's ear at regular intervals to obtain serum for the 
determination of tetracycline hydrochloride concentrations.
Therefore, whole blood drug concentrations were compared to serum 
drug concentrations to establish if they could be correlated. If a good 
correlation exists, whole blood could be used for the determination of 
tetracycline hydrochloride concentrations in capillary and venous 
samples. A good correlation had been found between plasma and 
whole blood theophylline concentrations in neonates (15).
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CHAPTER II 
EXPERIM ENTAL
M aterials
Tetracycline Hydrochloride, Nutritional Biochemicals Corp. 
Trichloroacetic Acid, Analyzed Reagent, J.T. Baker Co.
Calcium Chloride Dihydrate, ACS Reagent Grade, Allied Chemical Co. 
Ethyl Acetate, Analytical Reagent, Mallinkrodt Chemical Works. 
Sodium Barbital, Purified, Fisher Scientific Co.
Pre-cal m icro-hem atocrit tubes/heparinized (ammonium heparin), 
Becton, Dickinson and Company, Parsippany, N.J. 07054
P rocedures
Method of analysis:
Tetracycline was analyzed by Kohn’s method ( 14) which is based 
on the solvent extraction of a highly fluorescent tetracycline complex. 
In Kohn’s procedure an aliquot of sample (serum or urine) was 
diluted with distilled water to a total volume of 4.5 mL. To this was 
added 1 mL of a solution of 1.8 N trichloroacetic acid and 0.16 M 
calcium chloride (for the precipitation of proteins). The resulting 
solution was centrifuged. A 4 mL portion of supernatant was 
pipetted into a glass stoppered centrifuge tube containing 3.0 mL of 
ethyl acetate and 4 mL of 0.9 M sodium barbital. The tube was 
shaken vigorously for about two minutes and the phases were
8
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allowed to separate (barbital precipitates, but then dissolves in the 
ethyl acetate phase). The fluorescence of the ethyl acetate layer was 
measured using a spectrophotofluorometer. Kohn’s assay procedure
was modified for this research work to use a smaller sample size.
The following reagents were prepared in distilled water:
18.56 g sodium barbital diluted to 1(X) mL...........................0.9 M
29.41 g trichloroacetic acid diluted to 100 mL.................. 1.8 N
2.35 g calcium chloride dihydrate diluted to 100 mL...............0.16 M
Extraction procedure:
An aliquot of sample (serum, blood or aqueous solution for 
standard curves) was added to 2 mL of distilled water in a glass 
stoppered centrifuge tube of 15 mL capacity and vortexed. To this 
was added 0.5 mL of a solution of 1.8 N trichloroacetic acid and 0.16
M calcium chloride. The resulting solution was then centrifuged for
15 minutes at 3000 r.p.m. Two mL of the supernatant was 
transferred to a stoppered glass tube of 15 mL capacity containing 2 ’ 
mL of ethyl acetate and 2 mL of 0.9 M sodium barbital. The 
resulting solution was vortexed at a high speed for 2 minutes and the 
phases allowed to separate.
M easurement of fluorescence:
The fluorescence of the ethyl acetate layer was measured using a 
spectropho tofluorom eter.^  Maximum sensitivity for tetracycline
® Aminco-Bowman spectrophotofluorometer
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hydrochloride was obtained when the excitation wavelength was set 
at 390 nm and emission wavelength at 515 nm.
Standard curves for tetracvcline hvdrochloride:
Standard curves were prepared for tetracycline hydrochloride 
concentrations in the range of 0.1 mcg/mL to 100 mcg/mL. All drug 
dilutions were made in distilled water.
100 mg (tetracycline hydrochloride)
diluted to 100 mL.....................................................................   . 1000 mcg/mL
10 mL (1000 mcg/mL) diluted to 100 mL.......................... 100 mcg/mL
7.5 mL (1000 mcg/mL) diluted to 100 mL..................75 mcg/mL
5.0 mL (1000 mcg/mL) diluted to 100 mL..................50 mcg/mL
2.5 mL (1000 mcg/mL) diluted to 100 mL................. 25 mcg/mL
1.0 mL (1000 mcg/mL) diluted to 100 mL.................10 mcg/mL
5.0 mL (100 mcg/mL) diluted to 100 mL.......................... 5 mcg/mL
2.5 mL (100 mcg/mL) diluted to 100 mL.............................2.5 mcg/mL
1.0 mL (100 mcg/mL) diluted to 100 mL.............................1 mcg/mL
1.0 mL (50 mcg/mL) diluted to 100 mL............................ 0.5 mcg/mL
1.0 mL (10 mcg/mL) diluted to 100 mL............................ 0.1 mcg/mL
Standard curves were then prepared for tetracycline hydrochloride 
concentrations in the range of 1 mcg/mL to 25 mcg/mL. All dilutions 
were freshly prepared in duplicate in distilled water at the beginning 
of each experiment.
100 mg (tetracycline hydrochloride)
diluted to 100 mL........................................................................  1000 mcg/mL
2.5 mL (1000 mcg/mL) diluted to 100 mL.......................... 25 mcg/mL
2.0 mL (1000 mcg/mL) diluted to 100 mL.......................... 20 mcg/mL
1.5 mL (1000 mcg/mL) diluted to 100 mL.......................... 15 mcg/mL
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1.0 mL (1000 mcg/mL) diluted to 100 mL......................... 10 mcg/mL
5.0 mL (100 mcg/mL) diluted to 100 mL............................5 mcg/mL
1.0 mL (100 mcg/mL) diluted to 100 mL........................... 1 mcg/mL
Prelim inary spec trof 1 u orome try studies:
The purpose of this study was to attain maximum sensitivity 
using the spectrophotofluorometer for a small sample size, while 
maintaining adequate peak/trough resolution. A variety of slit 
settings and cells were evaluated. Initially, round glass sample tubes 
of size 0.8 cm x 7 cm were utilized. However, 1.0 cm rectangular 
quartz cells were used for all analysis procedures. Reflecting mirrors 
were placed in the mirror holder of the cell compartments to 
increase the sensitivity. The quartz cells were rinsed three or four 
times with ethyl acetate between measurements. For routine 
analysis, cuvettes and pipettes were washed in 20% nitric acid. All 
other glassware was washed with laboratory detergent solution, 
rinsed at least three times with distilled, de ionized water and 
allowed to dry in a dust free area in order to prevent fluorescent 
im p u rities .
Sample size selection:
Initially a sample size of 100 pL was chosen for analysis. This 
was followed by a reduction in sample size to 50 pL obtained with 
calibrated glass capillary tubes. Heparinized capillary tubes were 
used for collection of blood samples. It was not feasible to draw 
50 pL  blood samples from the rabbit ear capillaries at regular 
intervals. Therefore, it was necessary to further reduce the sample
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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size by using heparinized microhematocrit capillary tubes. The 
volume of these tubes was determined to be 15.7 pL  by
measurement of the weight increase when filled to mark with 
distilled water, as shown in Table I.
T ab le  I. D e te rm in a tio n  o f volum e o f h ep arin ized  
m ic ro -h em a to c rit c a p illa ry  tu b es  used fo r 
co llec ting  b lood sam ples.
WEIGHT OF WEIGHT OF DIFFERENCE
FILLED TUBES EMPTY TUBES IN WEIGHT
(gram s) (gram s) (g ram s)
0 .235 0 .219 0 .016
0 .2 3 4 0 .219 0 .015
0 .2 3 4 0 .218 0 .0 1 6
0 .2 3 2 0 .217 0 .015
0 .235 0 .219 0 .0 1 6
0 .2 3 7 0 .2 2 0 0 .017
0 .2 3 5 0 .2 2 0 0 .015
0 .235 0 .219 0 .0 1 6
0 .235 0 .219 0 .0 1 6
0 .2 3 2 0 .217 0 .015
Average weight difference = 0.0157 g, std. dev. = 0.0006.
Volume of capillary tubes = 15.7 pL .
In vivo evaluation of tetracvcline hvdrochloride concentrations:
Three domestic white rabbits, weighing 1.5 to 2.0 kg were 
housed single in stainless steel cages in a separate animal room at an 
environm ental temperature of 19-20^ C. Rabbits were fed rabbit 
chow, and had free access to drinking water.
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Surgical procedures:
The rabbit was restrained in a special holding box as shown in 
Figure 1. The upper portion of the ear lobe was cleanly shaven. Hot 
water was applied to the outer portion of the ear and rubbed briskly 
with hand to cause vasodilation.
atm»
Figure 1. Holding box for rabbits prior to intravenous drug 
ad m in is tra tio n .
Intravenous tetracycline studv:
The rabbits were injected with the antibiotic at 10 mg per kg of 
bodyweight. The volume of drug solution to be injected was kept at 
a constant value of 0.5 mL, as it is not feasible to inject a larger 
volume. The drug concentration to be injected was calculated as 
follows.
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Concentration of drug = Animal weight x Dose of the drug
Volume of drug solution
The solution was freshly prepared and immediately injected in order
to prevent turbidity caused by decomposition of the drug. The drug
solution was injected into the marginal ear vein using a standard
butterfly intravenous injection needle and syringe (Figure 2).
Figure 2. Rabbit marginal ear veins and arteries.
(Syringe and needle in blood vessel).
Rabbits were allowed to move freely in a room after injection to 
aid in better blood circulation. The marginal ear vein was poked or 
raptured with a needle to collect venous blood samples. Capillary 
blood samples were collected by pricking the ear lobe tip with a 
lancet, taking care to avoid the branches of the marginal ear vein. 
Both samples were collected in heparinized capillary tubes (capillary 
action) to the calibrated mark. The blood samples were collected in 
duplicate for tetracycline assay at 0.5, 1, 2, 3, 4, 5 and 6 hours.
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Samples were refrigerated until analysis. Analysis was completed 
within 12 hours of sample collection.
A blank (blood sample obtained prior to injection; extracted by 
Kohn's procedure) was used for zero adjustment. A tetracycline 
hydrochloride concentration of 25 mcg/mL in distilled water was 
used to set the relative intensity at 90 on the meter of 
spectrophotofluorometer. The relative intensity values of all the 
other standard solutions were recorded in the descending order. The 
relative intensity values of capillary and venous blood samples were 
recorded consecutively starting with the 0.5 hour sample to the 6 
hour sample. Intermittant measurements of the blank settings and 
the highest standard (25 mcg/mL) were checked to ensure that they 
gave relative intensities of 0 and 90 respectively.
Comparison of whole blood and serum drug concentrations:
The purpose of this experiment was to determine whether the 
tetracycline concentrations in whole blood and serum can be 
correlated. In order to carry out capillary blood analysis, it is 
necessary to collect a sufficient volume of blood to allow it to clot, so 
that serum can be obtained. This is not feasible with a small time 
intervals between capillary blood samples.
Two rabbits weighing 2.4 kg and 1.9 kg (rabbits 1 and 2) were 
injected with antibiotic at 10 mg per kg body weight. A time 
interval of 30 minutes was placed between these two injections to 
allow sufficient time for sample collection. For the analysis of whole 
blood, samples were collected directly from the marginal ear vein in 
heparinized capillary tubes. In case of serum, a sample volume of
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1-2 mL was collected in blood collecting tubes, allowed to clot, 
centrifuged and serum separated. The serum was drawn into 
heparinized capillary tubes for further analysis. Blood samples were 
collected in duplicate for tetracycline assay at 1, 2, 3, 4, 5 and 6 
hours. Samples were refrigerated until analysis.
Comparison of drug concentrations in capillary and venous blood:
Three rabbits (A, B and C) weighing 1.92 kg, 1.82 kg, and 1.48 kg 
respectively were injected with the antibiotic at 10 mg per kg body 
weight. Whole blood samples were used in this study. Capillary and 
venous blood samples were collected in duplicate in heparinized 
capillary tubes at 0.5, 1, 2, 3, 4, 5 and 6 hours. Samples were 
refrigerated until analysis.
The experiment was performed in triplicate on each rabbit, with a 
"washout" period of 3 days between runs. Samples were collected in 
duplicate for each set of experiments for the three rabbits.
Standards were extracted and analyzed in duplicate for each 
experiment. Average relative intensity values were used in the 
preparation of standard curves. The unknown concentration was 
calculated using the following equation.
Y = a + bX
Where: Y = relative intensity of the sample.
a = intercept.
b = slope of the straight line.
X = unknown concentration.
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Data analysis:
The average values of the capillary blood concentrations for the 
three rabbits in each experiment were plotted against the average 
values of the venous blood concentrations. A linear regression 
analysis was carried out on this data. The results were further 
analyzed by analysis of covariance (ANCOVA), since there are more 
than two variables involved (25). An analysis of covariance tests a 
dependant variable Y for homogeneity among group means in a 
design similar to that of the closely related analysis of variance. 
Analysis of covariance of the data (capillary and venous blood 
concentrations with respect to time) was performed using the 
"Biometry" statistical program software (25) on a Zenith data systems 
com pu ter.
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CHAPTER III 
RESULTS AND DISCUSSION
Standard curves for tetracvcline_hydrochlorid£:
In prelimnary experiments, an aliquot of 100 pL of each standard 
was used with Kohn’s extraction procedure in the preparation of the 
standard curves. Standard curves for drug concentrations in the 
range of 0.1 mcg/mL to 100 mcg/mL were linear with correlation 
coefficients of 0.991 or better.
When the in-vivo study was carried out it was observed that the 
drug concentration in the 0.5 hour blood sample (first blood sample 
after the injection) did not exceed 20 mcg/mL. When an aliquot of 
15.7 microliters (volume of the capillary tubes utilized in drawing 
samples) of each standard was used, the minimum tetracycline 
hydrochloride concentration analyzable with confidence was found to 
be 1 mcg/mL. Therefore, standard curves were prepared for 
tetracycline hydrochloride concentrations in the range of 1 mcg/mL 
to 25 mcg/mL.
The extraction procedure for determination of tetracycline 
hydrochloride for the standard curves was the same as the analysis 
procedure used for whole blood and serum samples. Aqueous 
solutions of tetracycline hydrochloride were used for the standard 
curve. It was not practical to prepare standard curves by spiking 
standard whole blood and serum samples. The reasons are:
(1) The volumes of serum and blood necessary would require 
sacrificing many rabbits. (2) It is difficult to handle non-heparinized
1 8
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whole blood samples. (3) Since a very small sample size (15.7 pL) is 
diluted to 2 mL for the analysis, there should be little or no 
difference in using serum, whole blood or aqueous samples in the 
extraction procedure. When whole blood samples were used for 
analysis, the addition of these samples to water resulted in 
hemolysis. The diluted samples were stored in the refrigerator for at 
least two hours before analysis.
Prelim inary spectrofluorom etry study:
Maximum sensitivity for the analysis of tetracycline 
hydrochloride was determined to be at an excitation wavelength of 
390 nm and an emission wavelength of 515 nm. When glass sample 
tubes of 0.8 cm x 7 cm were used the best slit setting was obtained 
with the excitation monochromator exit slit (Ex) at 2 mm and the 
emission monochromator entrance slit (Em) and the exit slit to the 
photomultiplier tube (PM) at 5 mm. Use of 1 cm rectangular quartz 
cells along with reflecting mirrors in the mirror holders of the cell 
compartment and the same slit setting gave a fourfold increase in 
sensitivity. The mirrors reflect the fluorescence of the sample 
solution, thus increasing the relative intensity measurement. By 
increasing the excitation monochromator exit slit to 5 mm, a ninefold 
increase in sensitivity was realized with very little loss of resolution. 
In this case the excitation slit is opened wide to excite as many 
molecules as possible and thus increase sensitivity.
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CQtnparison of w hole blood and serum drug concentrations:
The spectrophotofluorometer parameters for this part of the 
study are shown in Table II. Consistent relative intensity values 
were obtained for tetracycline hydrochloride concentrations in the 
range of 1 mcg/mL to 25 mcg/mL (Table III). The standard curve 
for these drug concentrations was highly linear with a correlation 
coefficient (R^> of 0.999 (Fig 3).
T ab le  II . S p e c tro f lu o ro m e te r  p a ra m e te rs .
PARAMETER SETTING
V oltage 800 'F
Slits Ex: 5, Em: 5, PM: 5 mm
Blank 3.34 X 100 (subtracted)
Excitation wavelength 390 nm
Emission wavelength 515 nm
S ensitiv ity 79
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T ab le  I I I . C o n c e n tra tio n  vs. re la tiv e  flu o rescen ce  In tensity  
fo r te tracy c lin e  hyd ro ch lo rid e  In w ater: (K ohn 's
ex trac tio n  p ro ced u re  using 15.7 p.L of sam ple). 
S tan d a rd  fo r com parison of whole blood and 
se ru m  c o n c e n tra tio n s .
CONCENTRATION RELATIVE RELATIVE AVERAGE
( m c g / m L ) INTENSITY INTENSITY RELATIVE
Sample 1 Sample 2 INTENSITY
25 90 90 90
20 73 68 70.5
15 55.5 50.5 53
10 36 38 37
5 16.5 20.5 18.5
1 3.4 5.2 4.3
0 0 0 0
100
i
8 0  -
lU 6 0  -
UJ
> 4 0  -
<
20  -LU
OC
0 10 20 3 0
CONCENTRATION (mcg/mL)
Figure 3. Concentration vs. relative fluorescence intensity of 
tetracycline hydrochloride in water: (Kohn's extraction 
procedure using 15.7 pL of sample). Standard curve for 
comparison of whole blood and serum drug concentrations.
Y = 0.520 + 3.548X R = 0.999
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The data obtained from sampling of whole blood and serum of 
rabbits 1 and 2 are shown in Tables IV and V respectively. The 
average concentration values obtained from whole blood and serum 
samples of both the rabbits are shown in Table VI.
Linear regression analysis of the average whole-blood versus 
serum drug concentrations (data in Table VI) showed a good linear 
correlation (Figure 4). Exact agreement between tetracycline
hydrochloride concentrations in blood and serum would result in an
2
equation with a slope of 1.00, an intercept of 0.0 and an R of 1.00.
2
The actual slope was 0.907 with an intercept of 0.339 and an R of 
0.985, thus showing only a small difference between whole blood 
and serum drug concentrations. A whole blood tetracycline 
hydrochloride concentration of 10.0 pg/mL corresponds to a serum 
concentration of 9.41 pg/mL using the regression equation. 
Therefore, it was concluded that use of whole blood samples for 
tetracycline hydrochloride analysis was valid for this study.
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T ab le  IV . T e tracy c lin e  h y d ro ch lo rid e  co n cen tra tio n s  In 
w hole b lood .
TIME
(Hours)
RELATIVE 
INTENSITY 
Sample 1
OONC
(mcg/mL)
RELATIVE 
INTENSITY 
Sample 2
GONC
( m c g / m L )
AVERAGE
GONC
( m c g / m L )
Rabbit 1
1.0 33 .0 9.154 39 .0 10.846 10.000
2.0 20 .0 5.490 25 .0 6.900 6.195
3 .0 12.0 3.236 18.5 5.068 4.152
4 .0 10.5 2.813 12.5 3.377 3.095
5 .0 6.0 1.545 9.4 2.503 2.024
6.0 4.2 1.037 7.6 1.995 1.516
Rabbit 2
1.0 30 .0 8.318 25 .0 6.900 7.605
2.0 16.5 4.504 13.5 3.658 4.081
3.0 13.0 3.517 10.0 2.672 3.095
4 .0 9.5 2.531 8.1 2.136 2.334
5 .0 8.0 2.108 4.6 1.150 1.629
6 .0 5.4 1.375 3.9 0.953 1.164
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Table  V. T e tra c y c lin e  h y d ro c h lo rid e  c o n c e n tra tio n s  
In serum .
TIME
(Hours )
RELATIVE 
INTENSITY 
Sample 1
GONC
(mcg/mL)
RELATIVE 
INTENSITY 
Sample 2
GONC
( m c g / m L )
AVERAGE
GONC
( m c g /m L )
R a b b it 1
1.0 36.0 10.000 30.5 8.450 9.225
2.0 22.5 6.195 19.0 5.209 5.702
3.0 16.0 4.363 12.0 3.236 3.800
4,0 13.0 3.517 9.1 2.418 2.968
5.0 9.4 2.503 6.4 1.657 2.080
6.0 6.3 1.629 4.5 1.122 1.376
Ra bb i t 2
1.0 24.5 6.759 29.5 8.168 7.464
2.0 13.5 3.658 18.0 4.927 4.293
3.0 12.0 3.236 16.0 4.363 3.800
4.0 9.2 2.446 12.0 3.236 2.841
5.0 6.4 1.657 9.4 2.503 2.080
6.0 3.3 0.784 7.1 1.855 1.320
T ab le  VI. A verage te tra c y c lin e  h y d ro c h lo rid e  
co n cen tra tio n s  o b ta ined  from  whole blood and  
serum  sam ples of R abbit 1 and R abbit 2.
AVERAGE 
WHOLE BLOOD 
œNŒNTRATION 
( m c g / m L )
AVERAGE
SERUM
CONCENTRATION
( m c g / m L )
10.000
6.195
4.152
3.095
2.024
1.516
Rabbit 1
9.225
5.702
3.800
2.968
2.080
1.376
Rabbit Z
7.605
4.081
3.095
2.334
1.629
1.164
7.464
4.293
3.800
2.841
2.080
1.320
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Figure 4.
CONCENTRATION (mcg/mL) 
in WHOLE BLOOD
Relationship of whole blood and serum tetracycline 
hydrochloride concentrations.
Y = 0.339 + 0.907X R = 0.985
Comparison of drug concentrations in capillary and venous blood:
The spectrophotofluorometer parameters for study on rabbit A 
are shown in Table VII. In preparation of the standard curve, 
consistent relative intensity values were obtained for tetracycline 
hydrochloride in the concentration of 1 mcg/mL to 25 mcg/mL
(Table VIII). A plot of average relative fluorescence intensity versus
2concentration was highly linear with a correlation coefficient (R ) of 
0.999 (Figure 5). Similar standard curves were obtained for studies 
on Rabbits B and C. The data are shown in Tables XIV-XVII and 
Figures I I  and 12 in the supplemental data section.
The capillary and venous blood concentrations of tetracycline 
hydrochloride in Rabbits A, B and C are shown in Tables IX and X. 
Plots of concentration vs. time and log concentration vs. time for the 
capillary and venous blood samples for Rabbit A are shown in
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Figures 6-9. Similar plots of the data from Rabbits B and C are 
shown in Figures 13-20 in the supplemental data section. These 
graphs clearly indicate that tetracycline hydrochloride follows a 
biexponential elimination in rabbits after intravenous injection. The 
terminal portion of the data (after 2 hours) is log-linear, consistent 
with a first order elimination of the drug following an initial 
distribution phase. The mean elimination half life was 2.141 hours 
for the three rabbits. These results are consistent with previous 
reports on the pharmacokinetics of tetracycline in rabbits in which 
the elimination was found to be biexponential with a terminal half- 
life of 2.0 hours (22).
T ab le  V II. S p e c tro f lu o ro m e te r  p a ra m e te rs .
PARAMETER SETTING
V oltage 800 T
Slits Ex: 5, Em: 5, PM: 5 mm
Blank Set 1: 2.96 X 100 (subtracted)
Set 2: 2.33 X 100 (subtracted)
Set 3: 1.37 X 100 (subtracted)
Excitation wavelength 390 nm
Em ission wavelength 515 nm
S ensitiv ity Set 1: 68
Set 2: 71
Set 3: 76
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T ab le  V III . C o n c e n tra tio n  vs. re la tiv e  fluo rescence  in ten s ity
fo r te tracy c lin e  hyd ro ch lo rid e  in w ater: (K ohn 's
ex trac tio n  p ro ced u re  using 15.7 p i of sam ple). 
S tan d a rd  fo r com parison  of cap illa ry  and  
venous blood d rug  concen tra tions fo r R abb it A.
CONCENTRATION
( m c g / m L )
RELATIVE INTENSITY 
SETl SET 2 SET 3
RELATIVE STD. 
INTENSITY DEV. 
(Avera ge)
25 9 0 89 9 0 88 9 0 9 2 89.83 1.33
2 0 7 0 67.5 70.5 65.5 7 1 73 69.58 2.67
15 56.5 52.5 54.5 52.5 54.5 51.5 53.67 1.83
10 37 35 37.5 32.5 37 38 36.17 2.07
5 18.5 16 1 8 1 9 1 8 19 18.08 1.11
1 5.0 6.0 4.4 3.4 4.2 3.8 4.47 0.93
0 0 0 0 0 0 0 0 0
100
>•
I -
I
g s
8 0  -
6 0  -
4 0  -
5 20 -lU
OC
201 0 3 00
CONCENTRATION (mcg/mL)
Fig 5. Concentration vs. relative fluorescence intensity for
tetracycline hydrochloride in water: (Kohn’s extraction 
procedure using 15.7 pL  of sample). Standard curve for 
comparison of capillary and venous blood drug concentration
for Rabbit A. Y = 0.434 + 3.536X R = 0.999
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T a b l e l X . C ap i l la ry  blood concen tra t ions  of  te tracycline
hydrochloride for Rabbits A, B and C.
T IM E
( H o u r s )
C O NCENTRA TIO N
(m c g /m L )
A V E R A G E
CONC.
(m c g /m L )
STD .
D E V .
LOG
CONC.
SE T  1 SET  2 SET 3
a b a b a b Babbit A
0 .5 1 6 . 3 3 0 1 3 . 4 8 1 1 6 . 7 8 8 1 4 . 2 1 3 1 4 . 9 0 3 1 3 . 5 1 5 1 4 . 8 7 2 1 . 4 1 5 1 . 1 7 1
1 . 0 1 0 . 6 3 3 1 0 . 0 6 3 1 1 . 7 8 1 9 .6 3 5 1 1 . 0 1 5 9 .6 2 9 1 0 . 4 5 9 0 . 8 5 0 1 . 0 1 9
2 . 0 5 .0 7 9 6 .7 8 8 6 .9 1 7 5 .6 2 9 5 .7 4 3 5 .0 5 0 5 .8 6 8 0 . 8 1 4 0 . 7 6 5
3 . 0 3 .5 1 3 5 .2 2 2 4 .3 4 3 3 .6 2 7 3 .6 6 2 2 .9 6 8 3 .8 8 9 0 . 7 8 6 0 . 5 8 3
4 . 0 2 .3 7 3 3 .5 1 3 3 .7 7 0 3 .1 9 7 3 .2 4 6 2 .6 9 0 3 . 313 0 . 5 1 8 0 . 4 9 1
5 . 0 1 .5 1 9 2 .6 5 8 1.767 1 .480 2 .135 1.775 1 .889 0 . 4 4 4 0 . 2 6 7
6 . 0 1 .234 1 .519 1.195 1 .0 5 2 1.469 1.247 1 .286 0 . 1 7 6 0 . 1 0 6
S ET  1 SET 2 SET 3
a b a b a b Rabbit B
0 . 5 1 3 . 5 8 9 1 1 . 7 6 7 1 7 . 0 8 0 1 8 . 9 4 7 1 3 . 4 1 1 1 5 . 2 3 1 1 5 . 0 0 4 2 . 6 4 3 1 . 1 7 1
1 . 0 9 .3 8 4 8 .5 4 3 1 2 . 4 8 2 1 3 . 4 8 8 9 .491 1 0 . 6 1 1 1 0 . 6 6 7 1 . 9 3 9 1 . 0 2 2
2 . 0 5 .5 9 9 5 .1 7 9 7 .8 8 4 8 .6 0 3 5 .9 9 2 6 .8 3 2 6 .6 8 2 1 . 3 4 7 0 . 8 1 8
3 . 0 4 .7 5 8 3 .9 1 7 5 .5 8 5 6 .4 4 7 4 .1 7 2 4 .7 3 2 4 .9 3 5 0 . 9 3 8 0 . 6 8 7
4 . 0 3 .2 1 6 2 .7 9 6 3 .7 1 8 4 .2 9 2 3 .1 9 2 4 .0 3 2 3.541 0 . 5 6 9 0 . 5 4 5
5 . 0 2 .3 1 9 1 .590 2 .7 1 2 3 .7 1 8 2 .297 2 .6 3 3 2 .545 0 . 6 9 8 0 . 3 9 2
6 . 0 1.871 1 .422 1.821 2 .8 2 7 1.429 2 .1 2 9 1.917 0 . 5 2 3 0 . 2 7 0
S E T  1 SET 2 SET 3
a b a b a b Rabbit Ç
0 . 5 9 .7 7 2 1 1 . 4 3 6 9 .8 1 7 1 1 . 6 1 8 1 0 . 9 6 9 1 2 . 6 7 0 1 1 . 0 4 7 1 . 1 1 9 1 . 0 4 1
1 . 0 7 .2 9 4 8 .7 2 3 8 .8 4 8 7 .1 8 6 8 .417 9 .9 7 6 8 .4 0 7 1 . 0 4 7 0 . 9 2 2
2 . 0 3 .7 2 4 4 .7 2 4 4 .1 3 9 4 .9 7 0 4 .4 4 8 5 .5 8 2 4 .5 9 8 0 . 6 5 1 0 . 6 5 9
3 . 0 3 .1 5 3 4 .0 1 0 3 .7 2 3 2 .8 9 2 3 .455 4 .0 2 2 3 .5 4 3 0 . 4 6 1 0 . 5 4 6
4 . 0 2 .0 1 0 2 .7 2 4 3 .0 3 0 2 .0 8 9 2 .463 3 .3 1 4 2 .6 0 5 0 . 5 1 7 0 . 4 0 8
5 . 0 1 .5 8 2 2 .0 1 0 2 .1 7 2 1 .479 1.953 2 .3 5 0 1 .924 0 . 3 3 7 0 . 2 7 9
6 . 0 1.211 1 .524 1 .618 1.258 1 .074 1.612 1.383 0 . 2 3 2 0 . 1 3 6
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Table  X. Venous blood concentra t ions  of  te tracycline
hydrochloride for Rabbits A, B and C.
TIM E
(H o u r s )
CO NCENTRA TIO N
(m c g /m L )
A V E R A G E
CONC.
(m c g /m L )
STD .
D E V .
LOG
CONC.
SE T  1 SET  2 SET 3
a b a b a b Rabbit A
0 . 5 1 6 . 8 9 9 1 5 . 6 1 7 1 5 . 2 1 5  1 3 . 0 6 9 1 4 . 9 0 3 1 6 . 2 9 0 1 5 . 3 3 2 1 . 3 2 5 1 . 1 8 4
1 . 0 8 .6 3 9 9 .7 7 9 1 1 .0 6 6 8 .491 1 0 . 3 2 3 1 1 . 8 4 9 1 0 . 0 2 5 1 . 3 2 9 0 . 9 9 8
2 . 0 5 .6 4 9 4 .6 5 2 6 .0 5 9 4 .6 2 8 5 .6 0 4 6 .5 7 6 5 .5 2 8 0 . 7 7 2 0 . 7 3 9
3 . 0 4 .3 6 7 3 .085 3 .9 1 3 3 .6 2 6 3 .3 8 4 4 .6 3 3 3 .8 3 5 0 . 5 8 9 0 . 5 7 9
4 . 0 2 .9 4 3 1.946 3 .6 2 7 2 .6 2 5 3 .2 4 6 2 .9 6 8 2 .8 9 3 0 . 5 7 3 0 . 4 5 3
5 . 0 1 .661 1 .519 1.767 1 .910 2 .135 2 .9 6 8 1.993 0 . 5 2 2 0 . 2 8 9
6 . 0 0 .9 4 9 1 .234 1.481 1 .052 1.108 2 .0 5 2 1.313 0 . 4 0 6 0 . 1 1 1
SET 1 S ET  2 SET 3
a b a b a b Rabbit B
0 . 5 1 4 . 7 1 0 1 3 . 4 4 8 1 6 . 9 3 6  1 5 . 3 5 5 1 0 . 7 5 1 1 3 . 4 1 1 1 4 . 1 0 2 2 . 1 0 3 1 . 1 4 5
1 . 0 9 .8 0 4 1 1 . 0 6 6 1 1 . 6 2 0  1 0 . 3 2 7 7 .8 1 2 8 .9 3 2 9 .9 2 7 1 . 4 0 0 0 . 9 9 3
2 . 0 5 .3 1 9 4 .3 3 8 7 .3 0 9 6 .4 4 7 4 .8 7 2 5 .8 5 2 5 .6 9 0 1 . 0 8 2 0 . 7 4 9
3 . 0 3 .7 7 7 3 .3 5 6 5 .1 5 4 4 .4 3 6 3 .6 1 2 4 .4 5 2 4 .131 0 . 6 6 9 0 . 6 1 2
4 . 0 2 .3 7 5 2 .7 9 5 4 .1 4 9 3 .4 3 0 2 .4 9 3 3 .1 9 2 3 .0 7 2 0 . 6 6 3 0 . 4 7 9
5 . 0 1 .5 3 4 2 .1 7 9 2 .8 5 5 2 .3 9 6 1.597 2 .3 5 3 2 .1 5 2 0 . 5 0 7 0 . 3 2 2
6 . 0 1 .0 5 7 1.646 2 .1 9 5 2 .0 2 2 1.149 1.961 1 .672 0 . 4 7 6 0 . 2 0 7
S ET  1 S ET 2 SET 3
a b a b a b
0 . 5 1 1 . 2 9 3 1 2 . 8 6 4 8 .1 5 5 9 .2 6 3 9 .4 0 9 1 0 . 9 6 9 1 0 . 3 2 5 1 . 7 0 1 1 . 0 0 9
1 . 0 8 .8 6 5 9 .7 2 2 6 .0 7 8 7 .3 2 4 7 .2 8 3 8 .2 7 5 7 .9 2 5 1 . 2 9 8 0 . 8 9 4
2 . 0 4 .1 5 3 5 .1 5 2 3 .0 3 0 3 .7 2 3 3 .7 3 9 4 .8 7 3 4 . 11 2 0 . 7 9 0 0 . 6 0 7
3 . 0 3 .7 2 4 4 .2 9 5 2 .6 3 2 2 .1 1 6 2 .6 3 3 3 .455 3 .143 0 . 8 1 7 0 . 4 8 5
4 . 0 2 .5 8 2 2 .8 6 7 2 .1 9 9 1 . 812 2 .0 0 9 2 .7 4 7 2 .3 6 9 0 . 4 2 5 0 . 3 6 9
5 . 0 1 .8 1 0 2 .1 2 5 1 .756 1 .4 5 2 1.783 2 .1 2 3 1 .842 0 . 2 5 4 0 . 2 6 1
6 . 0 1 .1 2 5 1 .9 8 2 1.341 0 .9 8 1 0 .9 6 0 1 .726 1.353 0 . 4 1 9 0 . 1 2 3
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Figure 6. Plot of average capillary blood concentrations of 
tetracycline hydrochloride vs. time: Rabbit A.
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Figure 7. Plot of average venous blood concentrations of 
tetracycline hydrochloride vs. time: Rabbit A.
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Figure 8. Plot of log capillary blood concentrations of tetracycline 
hydrochloride versus time: Rabbit A.
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Figure 9. Plot of log venous blood concentrations of tetracycline 
hydrochloride versus time: Rabbit A.
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The relationship between capillary and venous blood 
concentrations of tetracycline hydrochloride was analyzed by least 
squares regression. The average capillary and venous blood 
concentrations from the studies on rabbits A, B and C are shown in 
Table XI. The concentrations in the table are the average values 
from the two determinations (a and b) of each set of experiments 
shown in Tables IX and X. The data in this table corresponds to the 
blood samples collected at the 0.5, 1, 2, 3, 4, 5 and 6 hours, 
re sp ec tiv e ly .
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
33
Table  XI. Average cap i l la ry  and venous concentra t ions  of
te tracycline hydrochloride for Rabbits  A, B and C
AVERAGE CAPILLARY 
CONCENTRATION 
( m c g / m L )
AVERAGE VENOUS 
CONCENTRATION 
( m c g / m L )
14.906
RABBIT A 
Set 1
16.258
10.348 9.209
5.934 5.151
4.938 3.726
2.943 2.445
2.089 1.614
1.377 1.092
15.501
RABBIT A 
Set 2
14.142
10.708 9.779
6.273 5.344
3.985 3.770
3.484 3.126
1.624 1.839
1.124 1.267
14.209
RABBIT A 
Set 3
15.596
10.323 11.086
5.397 6.090
3.315 4.009
2.698 3.107
1.955 2.552
1.358 1.580
12.678
RABBIT B 
Set 1
14.079
8.964 10.435
5.389 4.809
4.338 3.576
3.006 2.585
1.955 1.857
1.647 1.352
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AVERAGE CAPILLARY 
CONCENTRATION 
fmcg/mL^
AVERAGE VENOUS 
CONCENTRATION 
Cmce/mLl
18.014
RABBIT B 
Set 2
16.146
12.985 10.974
8.244 6.878
6.016 4.795
4.005 3.790
3.215 2.626
2.324 2.109
14.321
RABBIT B 
Set 3
12.081
10.051 8.372
6.412 5.362
4.452 4.032
3.612 2.843
2.465 1.975
1.779 1.555
10.579
RABBIT C 
Set 1
12.079
8.009 9.294
4.224 4.653
3.582 4.010
2.367 2.725
1.796 1.968
1.368 1.554
10.718
RABBIT C 
Set 2
8.708
8.017 6.701
4.555 3.377
3.308 2.374
2.560 2.006
1.826 1.604
1.438 1.161
11.820
RABBIT C 
Set 3
10.189
9.197 7.779
5.015 4.306
3.739 3.044
2.889 2.378
2.152 1.953
1.343 1.343
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The results of linear regression analysis of the data in Table XI 
are shown in Figure 10. Exact correlation between tetracycline 
hydrochloride concentrations in capillary and venous blood samples 
would result in a slope of 1.00, an intercept of 0.0 and a correlation 
coefficient (R) of 1.00. The slope of the regression line for the 63 
data points is 1.00 with an intercept of 0.354 (positive capillary 
concentration bias) and a correlation coefficient of 0.978. These 
results indicate a high degree of correlation between the sampling 
methods (capillary vs venous blood). For the 63 paired samples the 
drug concentration in the capillary samples was not substantially 
different from those in venous blood samples.
20
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O E
>
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<
o.
<
Ü
10  -
0  1 0
VENOUS CONCENTRATION 
(mcg/mL)
Figure 10. Relationship between capillary and venous blood 
concentrations of tetracycline hydrochloride.
Y = 0.354 + 1 .OOOX R= 0.978
20
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The results of linear regression analysis on the nine individual 
sets of capillary vs venous blood tetracycline hydrochloride 
concentrations (from Table XI) are shown in Table XXL The slopes of 
the regression lines for the nine data sets ranged between 0.830 and 
1.207, intercepts ranged between - 0.280 and 1.003, and all 
correlation coefficients (R) were greater than 0.991.
Table XII. L inear regression analysis of capillary vs. 
venous tetracycline hydrochloride 
concentrations. Equation: Y = a + bX.
Y = capillary drug concentration, a = intercept, 
b = slope, X = venous drug concentration.
Set 1 Set 2 Set 3
Intercept (a) = 1.003 - 0 .159 - 0 .2 8 0
Rabbit A Slope (b) = 0 .899 1.116 0 .936
C orrelation
coefficient (R) = 0.991 0 .9 9 9 0 .999
Intercept (a) = 0 .835 0 .223 0 .019
Rabbit B Slope (b) = 0 .830 1.125 1.186
C orrelation
coefficient (R) = 0 .994 0 .998 0 .999
Intercept (a) = 0 .070 0 .1 6 2 - 0 .036
Rabbit C Slope (b) = 0 .866 1.207 1.175
C orrelation
coefficient (R) = 0 .999 0 .997 0 .999
The small positive bias in the capillary concentration of 
tetracycline hydrochloride seen in Figure 10 (intercept = 0.354) does 
not appear to be systematic. From the data in Table XI it can be seen 
that the drug concentrations in capillary blood samples exceeded that 
found in the venous blood samples in five of the nine data sets. In
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the other four data sets the venous blood tetracycline hydrochloride 
concentrations were greater than those in the capillary blood 
samples collected at the same time. The individual regression data 
shown in Table XII further indicates this bias is not systematic. In 
the five data sets where the capillary drug concentration was greater 
than the venous drug concentration (slopes greater than 1.00), the 
intercept values were positive in three of the five cases. In the data 
sets where the slopes were less than 1.00, the intercepts were 
positive in three of the four cases. These results indicate that the 
small positive bias of the Y intercept observed in linear regression of 
the combined data sets (63 pairs) is not systematic. Therefore, 
analysis of tetracycline hydrochloride concentrations in capillary 
blood samples provides an accurate and unbiased estimate of the 
concentrations in the venous blood.
It can be seen fom Table XI that the largest variation between 
capillary and venous concentrations of tetracycline hydrochloride 
values occurred during the distribution phase (before two hours).
The difference here may be real because during the distribution 
phase the concentration of the drug in the central compartment 
(tissues and fluids with which a drug rapidly equilibrates following 
administration) rapidly decreases while the concentration of the drug 
in the peripheral compartment (tissues and fluids with which a drug 
slowly equilibrates from the central compartment) increases. After 
the distribution is complete, the drug will be lost (eliminated) from 
both compartments at a proportional rate.
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Statistical analysis:
From the results discussed above it was concluded that a strong 
correlation exists between capillary and venous blood concentrations 
of tetracycline hydrochloride and that measurement of capillary 
concentrations of the drug provides an accurate and unbiased 
estimate of the venous concentrations. The statistical validity of 
these conclusions was evaluated by analysis of covariance (ANCOVA). 
Analysis of covariance is based on a linear model However, the drug 
concentration vs time data obtained in this study was not linear over 
the entire time period. As clearly seen from Figures 8 and 9, the 
data is not linear during the distribution phase (before two hours). 
Therefore, it was not possible to carry out analysis of covariance on 
the entire data set (during the entire time period) simultaneously.
The data shown in Figures 8 and 9 indicate that tetracycline blood 
concentrations can be described by a two compartment
(biexponential) model following intravenous administration. In this
case, the distribution and elimination phase can be described, 
mathematically, by linear models. However, since it was not 
practical to collect capillary blood samples more frequently than at 
the stated time periods, only two samples were collected during the 
distribution phase (at 0.5 and 1.0 hours). With only two data points 
in the distribution phase of each data set, statistical analysis of the
linearity and homogeneity of the data sets would not be valid.
Analysis of covariance was used to statistically evaluate the 
elimination phase (p phase) data obtained between 2 and 6 hours.
The concentration values were converted into the natural logarithms 
by the ANCOVA computer program and plotted versus time. These
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plots were linear. Regression analysis was carried out on these data 
points. The slopes of the regression lines were then compared. The 
ANCOVA program used in the data analysis also computes the 
common slope for all the data points ( p phase) for all the three 
experiments on each rabbit. This was used to calculate the 
elimination half-life of tetracycline hydrochloride in each rabbit.
Three sets of experiments were performed on each animal, with 
capillary and venous concentration values in duplicate for each set. 
The total number of groups were 12 (6 capillary and 6 venous). The 
concentration versus time values for each set was considered as one 
group. The statistic for computing regression was entered separately 
for each group. The ANCOVA program gives differences among 
adjusted means, testing for homogeneity of the Y intercepts and 
differences among the slopes, testing for homogeneity of slopes. In 
this study, only the difference in the slopes of the regression lines of 
each group was compared. The test statistic used in ancova is the 'F  
ra tio .
F = Mean square value of difference among separate slopes______________
Mean square value of deviation of each group from its separate slope
The computed 'F  ratio is then compared with the critical ’F  value. 
The critical ’F' value, which is a function of degrees of freedom for 
the denominator and significance level, is given in the table of F"
distribution (25). At a critical a  level (selected significance level), if
the computed ’F' ratio is greater than or equal to the critical 'F  value, 
then there is heterogeneity of the slopes of the regression lines. 
However if  the 'F* ratio is smaller than the critical 'F  value then the
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difference among the slopes is non significant, that is; the slopes are 
hom ogeneous.
The elimination phase (B phase) values were obtained from 
Tables IX and X (concentration values from 2 to 6 hours for rabbits A 
and C and 3 to 6 hours for rabbit B). Results obtained by comparison 
of slopes using the ANCOVA program can be seen in Table XIII. The 
degrees of freedom of the denominator of rabbit B is different from 
that of rabbits A and C because the concentration values at the two 
hour data point was not used for rabbit B. During initial ANCOVA 
analysis of the data from rabbit B, considerable variance was 
observed when the two hour data point was included. Therefore, the
concentration values from 3 to 6 hours were used for the statistical
analysis of rabbit B.
The critical ’F  value from the table of *F distribution at the
0.05 a  level for 11 degrees of freedom in the numerator and 36
degrees of freedom in the denominator is 2.11. This is greater than 
the computed 'F  ratios of 1.627 for rabbit A and 2.093 for rabbit C. 
This indicates homogeneity of slopes of regression lines at the 0.05 a  
level (P>0.05).
The critical F  values at the 0.001 a  level and at the 0.05 a  level
with 11 degrees of freedom in the numerator and 24 degrees of
freedom in the denominator are 4.50 and 2.22 respectively. The 
computed 'F  ratio for rabbit B is 3.890 which is smaller than the 
critical 'F  value at the 0.001 a  level but greater than the critical *F’ 
value at the 0.05 level. This indicates homogeneity of regression
slopes at the 0.001 a  level (p > 0.001, p < 0.05).
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An a  level of 0.05 was selected for the comparison of the slopes 
as it is the most commonly used level to show statistical significance. 
However, if the comparison of the slopes is carried out at the less 
stringent 0.001 a  level, the computed 'F' ratio for each of the three 
rabbits would be less than the critical 'F* value, indicating that the 
difference in slopes is not significant. Therefore, there is 
homogeneity of slopes of the twelve regression lines for the 
elimination phase data of each rabbit. Thus, it can be concluded that 
there is a good correlation statistically between the slopes of the 
elimination phase data of each rabbit when capillary and venous 
blood drug concentrations are compared.
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Table XIII. D ifferences among elim ination phase slopes
from ANCOVA.
SO U R C E  O F  
V A R IA T IO N
d f SS MS S i g n i f i c a n c e  
leve l  ( a )
F  V alue  
( C r i t i c a l )
F  Ratio  p r o b -  
(C o m p u te d )  v a l u e
A m o n g  s lo p e s 1 1 0 . 2 8 3  0 . 0 2 6 0 . 0 5 2 . 1 1 1 . 6 2 7
R abbit S um  o f  group (N S ) p >  0 .05
A d e v i a t i o n 3 6 0 . 5 6 9  0 . 0 1 6 0 . 0 0 1 3 . 9 5
Common slope = - 0.368
A m o n g  s lo p e s I 1 0 . 1 8 3  0 . 0 1 7 0 . 0 5 2 . 2 2 3 . 8 9 0 0 . 0 0 1
R abbit S u m  o f  group (N S) < p <
B d e v i a t i o n 2 4 0 . 1 0 2  0 . 0 0 4 0 . 0 0 1 4 . 5 0 0 . 0 5
Common slope = - 0.321
A m o n g  s lo p e s 1 1 0 . 1 9 8  0 . 0 1 8 0 . 0 5 2 . 1 1 2 . 0 9 3
R abbit S u m  o f  group (N S) p >  0 .05
C d e v i a t i o n 3 6 0 . 3 0 9  0 . 0 0 9 0 . 0 0 1 3 . 9 5
Common slope = - 0.291
df = degrees of freedom, ss = sum of squares, ms 
(NS) = Not statistically significant.
mean squares
Half-life of tetracycline:
The ANCOVA program used in this data analysis computes the 
common slope for all data points of all the groups under study for 
each rabbit. The data points (elimination phase concentration 
values) were converted into natural logarithmic form and plotted 
versus time. These plots were linear. The slopes of all the regression 
lines were taken into account and a common slope value was 
computed for the entire data for each rabbit. This was used to
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calculate the elimination half-life (ke) of the drug for each rabbit as 
show n.
Rabbit A: Slope = - 0.368.
ke = - slope = - ( - 0.368 ) = 0.368 hr-1. 
t i / 2  = 0.693/ke = 0.693/0.368 = 1.883 hours.
Rabbit B: Slope = - 0.321.
ke = 0.321 hr-1. 
t j / 2  = 2.159 hours.
Rabbit C: Slope = - 0.291.
ke = 0.291 hr-1. 
ti/2 = 2,381 hours
The average half life of tetracycline hydrochloride was
determined to be equal to 2.141 hours with a standard deviation of
0.249.
Significance of study:
The present study was a model using a very small sample size. 
Two of the studies reported in the literature (10 and 12) have used 
sample sizes of 15-20 pL, while the remaining studies (8, 19, 27 and 
28) have used sample sizes in the range of 500-800 pL. The larger 
volumes are possible using the standard finger lancet method when 
human beings are chosen as subjects; however collection of this 
volume does require significant milking of the finger wound. Results 
of the present study using 15.7 p i sample compare well to those 
reported in the literature.
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The establishment of an easier, more convenient blood collection 
method that involves a substantially smaller sample has clinically 
relevant significance. The finding that there is no significant 
difference in tetracycline hydrochloride concentration between 
venous and capillary blood shows that the collection of excess sample 
or the need to inflict a painful procedure on that population where 
venous collection is difficult is unwarranted. Thus drug monitoring 
of tetracycline concentrations can be performed accurately by 
measuring capillary blood tetracycline concentrations. Certainly the 
risks of capillary collection are less than with venipuncture.
An ideal method for drug determination should be rapid, 
incorporate a simple sampling technique and require a small sample 
size. Capillary sampling has considerable promise in large-scale 
screening studies, in pediatric studies, in neonatal studies or in any 
form of repetitive study because capillary blood sampling has 
substantial practical and economic advantages over venous blood 
sam pling.
This study shows that rabbits can be used as animal models for 
evaluation of the correlation between capillary and venous blood 
drug concentrations for various drugs for which therapeutic drug 
monitoring and pharmacokinetic analysis is done on a regular basis.
This study consisted of development of a model for use of small 
volume, capillary whole blood samples for the analysis of 
tetracycline hydrochloride concentrations. There were some 
limitations to this model. The use of rabbit ear blood samples 
restricted the volumes and sample times that could be used. The 
extraction and fluorescence analytical procedure, while sensitive, had
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a lower limit of 1,0 |ig/mL. With extension of this model to those in 
humans and with improved analytical techniques such as HPLC 
analysis with flourescence detection, some of these limitations may 
be overcome.
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CHAPTER IV 
CONCLUSIONS
The aim of this study was to investigate if concentrations of 
tetracycline hydrochloride in capillary blood can be correlated to 
those in venous blood.
The conclusions resulting from this study are:
1. There is no significant difference between tetracycline 
hydrochloride concentrations in capillary and venous blood. 
Therefore, capillary sampling for determination of tetracycline 
hydrochloride offers a convenient and viable alternative to venous 
sam pling.
2. A good correlation exists between whole blood and serum 
tetracycline hydrochloride concentrations. Therefore, whole blood 
can be used as an alternative to serum or plasma in determining 
tetracycline hydrochloride concentrations.
3. A very small sample volume can be used for assay of 
tetracycline hydrochloride in whole blood samples.
4. The study can be used as a model for use of a small sample 
volume in drug concentration studies. The collection of excess 
sample or the need to inflict a painful procedure on that population 
where venous blood collection is difficult is not necessary.
4 6
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CHAPTER V 
SUPPLEMENTAL DATA
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Figure 11.
CONCENTRATION (mcg/mL)
Concentration vs. relative fluorescence intensity for 
tetracycline hydrochloride in water: (Kohn’s extraction 
procedure using 15.7 pL of sample). Standard curve for 
comparison of capillary and venous blood drug concentrations
for Rabbit B. Y = 0.572 + 3.539X R = 0.999
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Figure 12.
CONCENTRATION (mcg/mL)
Concentration vs. relative fluorescence intensity for 
tetracycline hydrochloride in water: (Kohn's extraction 
procedure using 15.7 pL of sample). Standard curve for 
comparison of capillary and venous blood drug concentrations
for Rabbit C. Y = 0.452 + 3.546X R^= 0.999
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Figure 13. Plot of average capillary blood concentrations of
tetracycline hydrochloride versus time for Rabbit B.
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Figure 14. Plot of average venous blood concentrations of
tetracycline hydrochloride versus time for Rabbit B.
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Figure 15. Plot of log capillary blood concentrations of tetracycline 
hydrochloride versus time for Rabbit B.
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Figure 16. Plot of log venous blood concentrations of tetracycline 
hydrochloride versus time for Rabbit B.
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Figure 17. Plot of average capillary blood concentrations of
tetracycline hydrochloride versus time for Rabbit C.
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Figure 18. Plot of average venous blood concentrations of
tetracycline hydrochloride versus time for Rabbit C.
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Figure 19. Plot of log capillary blood concentrations of tetracycline 
hydrochloride versus time for Rabbit C.
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Figure 20. Plot of log venous blood concentrations of tetracycline 
hydrochloride versus time for Rabbit C.
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T ab le  XIV. S p e c tro f lu o ro m e te r  p a ra m e te r s .
PARAMETER SETTING
V oltage 8CX) T
Slits Ex: 5; Em: 5, PM: 5 mm
B lank Set 1: 3.16 X 100 (subtracted)
Set 2: 2.74 X 100 (subtracted)
Set 3: 3.63 X 100 (subtracted)
Excitation wavelength 390 nm
Em ission wavelength 515 nm
S ensitiv ity Set 1: 74
Set 2: 75
Set 3: 77
Table XV. C o n c e n tra tio n  vs. re la tiv e  fluorescence 
in te n s ity  fo r  te tracy c lin e  hydroch lo ride  in 
w a te r: (K ohn 's ex trac tion  p rocedure  using
15.7 p L  o f sam ple). S tandard  for com parison 
o f cap illa ry  and venous blood drug  
co n cen tra tio n s  fo r R abb it B.
CONCENTRATION
(m cg /m L )
RELATIVE INTENSITY 
SET l SET 2 SET 3
RELATIVE STD. 
INTENSITY DEV. 
(A verage)
25 9 0 9 2 9 0 87 9 0 94 90.5 2.34
20 6 8 71 .5 7 1 67 68.5 73.5 69.92 2.48
15 52 .5 54 .5 50.5 53.5 4 9 5 2 52.0 2.0
10 36 .5 3 9 34.5 36.5 37.5 38.5 37.08 1.63
5 18.5 19 19 21 18.5 20.5 19.42 1.07
1 4.4 3.6 3.8 3.0 3.5 5.9 4.03 1.02
0 0 0 0 0 0 0 0 0
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T ab le  XVI. S p e c tro f lu o ro m e te r  p a ra m e te r s .
PARAMETER SETTING
V oltage 8(X)
Slits Ex: 5; Em: 5; PM: 5 mm
B lank Set 1 : 1.28 X 1 0 0 (subtracted)
Set 2: 3.36 X 1 0 0 (subtracted)
Set 3: 2.43 X 1 0 0 (subtracted)
Excitation wavelength 390 nm
Em ission wavelength 515 nm
S en sitiv ity Set 1 : 82
Set 2: 73
Set 3: 83
T able X V II. C o n c e n tra tio n  vs. re la tiv e  fluorescence 
in te n s ity  fo r  te tracy c lin e  hyd roch lo ride  in 
w a te r: (K ohn 's  ex trac tion  p rocedure  using
15.7 p L  of sam ple). S tandard  fo r com parison 
o f cap illa ry  and venous blood d rug  
co n cen tra tio n s  fo r R abb it C.
CONCENTRATION
(m cg /m L )
RELATIVE INTENSITY 
SETl SET 2 SET 3
RELATIVE STD. 
INTENSITY DEV. 
(Average)
25 9 0 89 9 0 96 90 88 90.5 2.81
20 68 .5 71 .5 7 0 73 69 73 70.83 1.96
15 4 9 5 2 49.5 54.5 5 1 54 51.67 2.27
10 35 3 7 37 38 33 36 36.0 1.79
5 1 8 19 19 19 20 19 19.0 0.63
1 3.7 5.9 4.6 6.0 4.2 3.6 4.67 1.05
0 0 0 0 0 0 0 0 0
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